Puerarin inhibits caspase-3 expression in osteoblasts of diabetic rats

Molecular Medicine Reports

Volumn 5, Issue 6, 2012, Pages 1419-1422

  Liang, Junbo ^a   Chen, Haixiao ^a   Pan, Weibo ^a   Xu, Chunli ^a  

^a TAIZHOU HOSPITAL OF ZHEJIANG PROVINCE   (China)

Author keywords

Bone mineral density; Caspase 3; Diabetic osteoporosis; Puerarin

Indexed keywords

CASPASE 3; GLUCOSE; PUERARIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITY; CELL COUNT; CONTROLLED STUDY; CORTICAL BONE; DIABETES MELLITUS; DIABETIC OSTEOPOROSIS; GLUCOSE BLOOD LEVEL; MALE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOPOROSIS; PROTEIN EXPRESSION; RAT;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; BONE AND BONES; BONE DENSITY; CASPASE 3; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMMUNOHISTOCHEMISTRY; ISOFLAVONES; MALE; RATS; RATS, SPRAGUE-DAWLEY; VASODILATOR AGENTS;

RATTUS;

EID: 84860739072     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.854     Document Type: Article

References (32)

1. Zhang XM, Shi PH, Cao SH, Yu HJ, Azad J and Ling SC: Expression changes of transforming growth factor-beta1 and thrombospondin-1 in cavernous tissues of diabetic rats. Urol Int 84: 221-225, 2010.
2. Del Canizo Gomez FJ, Fernandez Perez C, Moreno Ruiz I, et al: Microvascular complications and risk factors in patients with type 2 diabetes. Endocrinol Nutr 58: 163-168, 2011.
3. Lu B, Gong W, Yang Z, et al: An evaluation of the diabetic kidney disease definition in chinese patients diagnosed with type 2 diabetes mellitus. J Int Med Res 37: 1493-1500, 2009.
4. Atsumi H, Kitada M, Kanasaki K and Koya D: Reversal of redox-dependent inhibition of diacylglycerol kinase by antioxidants in mesangial cells exposed to high glucose. Mol Med Report 4: 923-927, 2011.
5. Viegas M, Costa C, Lopes A, Griz L, Medeiro MA and Bandeira F: Prevalence of osteoporosis and vertebral fractures in postmenopausal women with type 2 diabetes mellitus and their relationship with duration of the disease and chronic complications. J Diabetes Complications 25: 216-221, 2011.
6. Hofbauer LC, Brueck CC, Singh SK and Dobnig H: Osteoporosis in patients with diabetes mellitus. J Bone Miner Res 22: 1317-1328, 2007. (Pubitemid 351339677)
7. Yamamoto M, Yamaguchi T, Yamauchi M, Kaji H and Sugimoto T: Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications. J Bone Miner Res 24: 702-709, 2009.
8. Miazgowski T, Pynka S, Noworyta-Zietara M, Krzyzanowska- Swiniarska B and Pikul R: Bone mineral density and hip structural analysis in type 1 diabetic men. Eur J Endocrinol 156: 123-127, 2007. (Pubitemid 46553912)
9. Norris R and Parker M: Diabetes mellitus and hip fracture: a study of 5966 cases. Injury 42: 1313-1316, 2011.
10. Yano S and Sugimoto T: Fracture risk in secondary osteoporosis. Clin Calcium 20: 1369-1377, 2010 (In Japanese).
11. Hie M, Iitsuka N, Otsuka T and Tsukamoto I: Insulin-dependent diabetes mellitus decreases osteoblastogenesis associated with the inhibition of Wnt signaling through increased expression of Sost and Dkk1 and inhibition of Akt activation. Int J Mol Med 28: 455-462, 2011.
12. Lana-Elola E, Rice R, Grigoriadis AE and Rice DP: Cell fate specification during calvarial bone and suture development. Dev Biol 311: 335-346, 2007. (Pubitemid 350046530)
13. Canalis E: The fate of circulating osteoblasts. N Engl J Med 352: 2014-2016, 2005.
14. Chan WH, Wu HJ and Shiao NH: Apoptotic signaling in methylglyoxal-treated human osteoblasts involves oxidative stress, c-Jun N-terminal kinase, caspase-3, and p21-activated kinase 2. J Cell Biochem 100: 1056-1069, 2007.
15. Tian F, Xu LH, Zhao W, Tian LJ and Ji XL: The optimal therapeutic timing and mechanism of puerarin treatment of spinal cord ischemia-reperfusion injury in rats. J Ethnopharmacol 134: 892-896, 2011.
16. +)-induced apoptosis in PC-12 cells. Neurosci Lett 487: 88-93, 2010.
17. Chung MJ, Sung NJ, Park CS, et al: Antioxidative and hypocholesterolemic activities of water-soluble puerarin glycosides in HepG2 cells and in C57 BL/6J mice. Eur J Pharmacol 578: 159-170, 2008. (Pubitemid 350309595)
18. Xu X, Zhang S, Zhang L, Yan W and Zheng X: The Neuroprotection of puerarin against cerebral ischemia is associated with the prevention of apoptosis in rats. Planta Med 71: 585-591, 2005. (Pubitemid 41133065)
19. Hwang YP and Jeong HG: Mechanism of phytoestrogen puerarin-mediated cytoprotection following oxidative injury: estrogen receptor-dependent up-regulation of PI3K/Akt and HO-1. Toxicol Appl Pharmacol 233: 371-381, 2008.
20. Wang Y, Yin L, Li Y, Liu P and Cui Q: Preventive effects of puerarin on alcohol-induced osteonecrosis. Clin Orthop Relat Res 466: 1059-1067, 2008.
21. Zhang Y, Zeng X, Zhang L and Zheng X: Stimulatory effect of puerarin on bone formation through activation of PI3K/Akt pathway in rat calvaria osteoblasts. Planta Med 73: 341-347, 2007. (Pubitemid 46910416)
22. Follak N, Kloting I and Merk H: Influence of diabetic metabolic state on fracture healing in spontaneously diabetic rats. Diabetes Metab Res Rev 21: 288-296, 2005. (Pubitemid 40716162)
23. Abbassy MA, Watari I and Soma K: The effect of diabetes mellitus on rat mandibular bone formation and microarchitecture. Eur J Oral Sci 118: 364-369, 2010.
24. Yamaguchi T, Yamamoto M, Kanazawa I, et al: Quantitative ultrasound and vertebral fractures in patients with type 2 diabetes. J Bone Miner Metab 29: 626-632, 2011.
25. Chang Y, Hsieh CY, Peng ZA, et al: Neuroprotective mechanisms of puerarin in middle cerebral artery occlusion-induced brain infarction in rats. J Biomed Sci 16: 9, 2009.
26. Chen WC, Hayakawa S, Yamamoto T, Su HC, Liu IM and Cheng JT: Mediation of beta-endorphin by the isoflavone puerarin to lower plasma glucose in streptozotocin-induced diabetic rats. Planta Med 70: 113-116, 2004. (Pubitemid 38299771)
27. Manonai J, Chittacharoen A, Udomsubpayakul U, Theppisai H and Theppisai U: Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women. Menopause 15: 530-535, 2008. (Pubitemid 351656760)
28. Wong KH, Li GQ, Li KM, Razmovski-Naumovski V and Chan K: Kudzu root: traditional uses and potential medicinal benefits in diabetes and cardiovascular diseases. J Ethnopharmacol 134: 584-607, 2011.
29. Mun JG, Grannan MD, Lachcik PJ, et al: Tracking deposition of a 14C-radiolabeled kudzu hairy root-derived isoflavone-rich fraction into bone. Exp Biol Med (Maywood) 235: 1224-1235, 2010.
30. Slee EA, Adrain C and Martin SJ: Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J Biol Chem 276: 7320-7326, 2001.
31. Miura M, Chen XD, Allen MR, et al: A crucial role of caspase-3 in osteogenic differentiation of bone marrow stromal stem cells. J Clin Invest 114: 1704-1713, 2004. (Pubitemid 40385526)
32. Chua CC, Chua BH, Chen Z, Landy C and Hamdy RC: Dexamethasone induces caspase activation in murine osteoblastic MC3T3-E1 cells. Biochim Biophys Acta 1642: 79-85, 2003. (Pubitemid 37338281)